Tag Archives: ATNM

Top 5 Undervalued Stocks To Watch For 2019

Lam Research (LRCX) is one of the backbones of the silicon microprocessor industry – today, pretty much every advanced chip is built with Lam technology – but the company remains undervalued and under followed. The company creates wafer fabrication equipment and offers services that allow chip makers (like Samsung (OTC:SSNLF), Toshibia (OTCPK:TOSBF), Elphia, Hynix and more) to build....More>>>

Top 10 Gold Stocks For 2018

On Friday, our Elite Opportunity Pronewsletter suggestedhad this to say about gold and leveraged gold ETFs:

It’s our thinking gold is likely to reverse its recent bullish trend one more time before we’ll know if it wants to finally bottom for a good while. It’s important to remember hindsight is always brilliant, and it can make a fool out of anyone. However, we’re....More>>>

Top 10 Low Price Stocks To Watch Right Now

Growth versus value investing is one of the major debates in the investment world.  Growth stocks seem to have outperformed their value counterparts over the past few years. But the winning streak of growth investing took a hit this year with value stocks regaining lost glory.

It is currently speculated that value investing will likely continue its winning run in the upcoming years.....More>>>

Top 10 Medical Stocks To Invest In Right Now

Stocks gained today as corporate earnings shined and inflation data showed no need for the Federal Reserve to rush a rate hike.

Getty Images

The S&P 500 rose 0.6% to 2,139.60 today, while the Dow Jones Industrial Average advanced75.54 points, or 0.4%, to 18,161.94. The Nasdaq Composite gained 0.9% to 5,243.84.

Citigroup’s Andrew Hollenhorst contends the inflation....More>>>

Top 10 Performing Stocks To Buy For 2018

I don’t know if the bull market in bonds is over or not, and nor do I care. I’m not in the business of playing Captain Prediction. I trade the markets that are in front of me, using my data-dependent 3G investing framework, explains Landon Whaley, editor of The Whaley Report.

As we begin 2017, all three gravities — fundamental, quantitative, and behavioral — are....More>>>

check stock

9 Ways to Save on Taxes in Retirement

The Roth Annuity: A Bright Star in Annuity Investing

Sex, Drugs and Pay-to-Play Fraud Hit New York Pension Fund: SEC

Ritholtz Wealth Management has created an environmental, social and governance version of its classic asset allocation models, known as the Portland Portfolio.

The portfolio’s name was jokingly coined by Josh....More>>>

stock market trader

No company’s market cap has ever reached $800 billion. Apple Inc. (NASDAQ: AAPL) is about to touch that goal. It only has to go 9% higher. And, based on the stock surge this year and speculation that the iPhone 8 will trigger unprecedented demand for the smartphone, it may breach that level soon.

Apple has posted the largest increase in share price this year of any component of the....More>>>

Top 10 High Tech Stocks For 2017

The crowd piled into investment-grade bonds last week as economic worries triggered an exodus out of risky assets. Reviewing the major asset classes for the week just passed through an ETF lens reveals sharply divided results. The safe-haven trade generated handsome gains for several ETFs representing broad measures of the global fixed-income realm for the five trading days through Feb. 5. Even....More>>>

stock symbols

A “Now Hiring!” sign stands on display next to the Jiffy Lube International Inc. booth during a Job News USA career fair in Overland Park, Kansas, on Wednesday, March 8, 2017. Applications for U.S. jobless benefits rebounded last week from a 44-year low, returning to a range that still shows strength in the labor market. Photographer: Luke Sharrett/Bloomberg

The bull market just....More>>>

Top 5 Medical Stocks To Buy Right Now

This Top Pick for 2017 may very well have the best and broadest early-stage oncology pipeline with 12 drug development candidates, suggests Jay Silverman, editor The Medical Technology Stock Letter.

Incyte (INCY) is poised for a strong performance in 2017 that will be driven by three major catalysts.

The first is that the firm’s drug Jakafi will continue to be a compelling....More>>>